General

Showing 1377–1392 of 2282 results

Article: P.09 Exome sequencing identifies mutation of CNOT3 in T-cell acute lymphoblastic leukaemia
€3.03 Add to cart
Article: P.10 Role of HH pathway in T cell acute lymphoblastic leukaemia (T-ALL)
€3.03 Add to cart
Article: P.11 Expression of ZAP-70 in CLL activates NF-?B signaling
€3.03 Add to cart
Article: P.12 Evaluation of CD200 expression in differential diagnosis of CD5+ B cell NHLs
€3.03 Add to cart
Article: P.13 G8 as a screening tool for older patients with malignant haemopathies: A surrogate for CGA?
€3.03 Add to cart
Article: P.14 Bendamustin shows distinct anti-tumoural responses in multiple myeloma patients that relapsed after prior bortezomib and lenalidomide treatment. A study on behalf of the MM BHS subcommittee
€3.03 Add to cart
Article: P.14.2 KIT D816 mutation in myeloid neoplasms: look out for systemic mastocytosis associated hematologic neoplasms (SM-AHN)
€3.03 Add to cart
Article: P.15 Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL): The Lymphoma Study Association (LYSA) Registry Data
€3.03 Add to cart
Article: P.15 Genomic profiling of myeloma: A comparison of cytogenetics, FISH and array- CGH analysis of 95 cases at diagnosis or follow up
€3.03 Add to cart
Article: P.16 Expression of TMEM45A, a candidate gene of chemoresistance, in a panel of neoplastic tissues
€3.03 Add to cart
Article: P.16 Malignant invasion of the cerebrospinal fluid in patients with a haematological malignancy: a single center retrospective study
€3.03 Add to cart
Article: P.17 Complete responses of the TEMPI syndrome to bortezomib
€3.03 Add to cart
Article: P.17 Feasibility of next generation flow for minimal residual disease in multiple myeloma on a BD FACS Lyric flowcytometer
€3.03 Add to cart
Article: P.18 Concurrent B-cell chronic lymphocytic leukaemia and multiple myeloma
€3.03 Add to cart
Article: P.18 Daratumumab therapy in patients with immunoglobulin light chain amyloidosis, a single center experience
€3.03 Add to cart
Article: P.19 Clonaly related monoclonal B-cell lymphocytosis and diffuse large B-cell lymphoma in a patient treated for EBV-positive Hodgkin lymphoma
€3.03 Add to cart

Article: P.09 Exome sequencing identifies mutation of CNOT3 in T-cell acute lymphoblastic leukaemia

Article: P.10 Role of HH pathway in T cell acute lymphoblastic leukaemia (T-ALL)

Article: P.11 Expression of ZAP-70 in CLL activates NF-?B signaling

Article: P.12 Evaluation of CD200 expression in differential diagnosis of CD5+ B cell NHLs

Article: P.13 G8 as a screening tool for older patients with malignant haemopathies: A surrogate for CGA?

Article: P.14 Bendamustin shows distinct anti-tumoural responses in multiple myeloma patients that relapsed after prior bortezomib and lenalidomide treatment. A study on behalf of the MM BHS subcommittee

Article: P.14.2 KIT D816 mutation in myeloid neoplasms: look out for systemic mastocytosis associated hematologic neoplasms (SM-AHN)

Article: P.15 Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL): The Lymphoma Study Association (LYSA) Registry Data

Article: P.15 Genomic profiling of myeloma: A comparison of cytogenetics, FISH and array- CGH analysis of 95 cases at diagnosis or follow up

Article: P.16 Expression of TMEM45A, a candidate gene of chemoresistance, in a panel of neoplastic tissues

Article: P.16 Malignant invasion of the cerebrospinal fluid in patients with a haematological malignancy: a single center retrospective study

Article: P.17 Complete responses of the TEMPI syndrome to bortezomib

Article: P.17 Feasibility of next generation flow for minimal residual disease in multiple myeloma on a BD FACS Lyric flowcytometer

Article: P.18 Concurrent B-cell chronic lymphocytic leukaemia and multiple myeloma

Article: P.18 Daratumumab therapy in patients with immunoglobulin light chain amyloidosis, a single center experience

Article: P.19 Clonaly related monoclonal B-cell lymphocytosis and diffuse large B-cell lymphoma in a patient treated for EBV-positive Hodgkin lymphoma